Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease [Original Article]

Conclusions—
Treatment of diabetes mellitus in patients with HF and chronic kidney disease is complex, and these patients are commonly treated with renal contraindicated AHMs, including over 6% receiving a thiazolidinedione, despite known concerns regarding HF. More research regarding safety and efficacy of various AHMs among HF patients is needed.

Source: Circulation: Heart Failure - July 12, 2016 Category: Cardiology Authors: Patel, P. A., Liang, L., Khazanie, P., Hammill, B. G., Fonarow, G. C., Yancy, C. W., Bhatt, D. L., Curtis, L. H., Hernandez, A. F. Tags: Diabetes, Type 2, Heart Failure Original Article Source Type: research